NeoPharm Co. Ltd.
092730.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$179.25B
Close$
Share Statistics
| Market cap | $179.25 Billion |
|---|---|
| Enterprise Value | $156.62 Billion |
| Dividend Yield | $600.00 (2.59%) |
| Earnings per Share | $1778.81 |
| Beta | 0.17 |
| Outstanding Shares | 15,641,256 |
Return
| Return on Equity | 15.25% |
|---|---|
| Return on Assets | 13.55% |
| Return on Invested Capital | 18.19% |
Valuation & Multiples
| P/E Ratio | 11.82 |
|---|---|
| PEG | 62.4 |
| Price to Sales | 1.21 |
| Price to Book Ratio | 0.89 |
| Enterprise Value to Revenue | 1.06 |
| Enterprise Value to EBIT | 4.26 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NeoPharm Co. Ltd.
141 employees
CEO: Kim Yang-soo Established on July 1, 2000, NeoPharm Co., Ltd. is a Daejeon, South Korea-based company that develops, produces, and markets a diverse range of cosmetic, medical, and health products. Its offerings notably include advanced skincare formu...